| ||||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Prostatitis (nonbacterial prostatitis, prostadynia) |
![]() |
|
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Some doctors recommend 200–500 mg of quercetin taken two to three times per day. Optimal intake remains unknown.
No clear toxicity has been identified. Early quercetin research suggested that large amounts of quercetin could cause cancer in animals.3 Most,4 5 6 but not all,7 current research finds quercetin to be safe or actually linked to protection from cancer.
Quercetin has been shown to cause chromosomal mutations in certain bacteria in test tube studies.8 Although the significance of this finding for humans is not clear, some doctors are concerned about the possibility that birth defects could occur in the offspring of people supplementing with quercetin at the time of conception or during pregnancy.
Since flavonoids help protect and enhance vitamin C, quercetin is often taken with vitamin C.
Are there any drug
interactions?
Certain medicines may interact with quercetin. Refer to drug interactions for a list of those medicines.
1. Miodini P, Fioravanti L, di Fronzo G, Capelletti V. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer 1999;80:1150–5.
2. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960–3.
3. Ishikawa M, Oikawa T, Hosokawa M, et al. Enhancing effect of quercetin on 3-methylcholanthrene carcinogenesis in C57B1/6 mice. Neoplasma 1985;43:435–41.
4. Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary flavonoids and cancer risk in the Zutphen elderly study. Nutr Cancer 1994;22:175–84.
5. Castillo MH, Perkins E, Campbell JH, et al. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 1989;351–5.
6. Stavric B. Quercetin in our diet: from potent mutagen to probably anticarcinogen. Clin Biochem 1994;27:245–8.
7. Barotto NN, López CB, Eyard AR, et al. Quercetin enhances pretumourous lesions in the NMU model of rat pancreatic carcinogenesis. Cancer Lett 1998;129:1–6.
8. Stoewsand GS, Anderson JL, Boyd JN, Hrazdina G. Quercetin: a mutagen, not a carcinogen in Fischer rats. J Toxicol Environ Health 1984;14:105–14.
| |||||||